Pular para o conteúdo

Interações medicamentosas

Lorlatinib + Mitotane

Gravidade: Contraindicada

Lorlatinib and Mitotane: contraindicated interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Mitotane is a strong CYP3A4 inducer with a very long half-life, and can markedly lower lorlatinib exposure. This may lead to loss of efficacy and hepatotoxicity.

O que esta interação significa em palavras simples

Lorlatinib and Mitotane are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Lorlatinib belongs to Oncology; Mitotane belongs to Oncology.

Nível de evidência: Moderate

Por que acontece

Mitotane induces CYP3A4 and increases lorlatinib metabolism.

O que fazer

Avoid the combination; because mitotane persists for weeks to months, choose an alternative to lorlatinib or other therapy.

O que perguntar ao farmacêutico

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Lorlatinib e Mitotane, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Lorlatinib with Mitotane?

MediHelp rates the interaction as contraindicated. Lorlatinib and Mitotane are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Mitotane is a strong CYP3A4 inducer with a very long half-life, and can markedly lower lorlatinib exposure. This may lead to loss of efficacy and hepatotoxicity.

How serious is the interaction between Lorlatinib and Mitotane?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; because mitotane persists for weeks to months, choose an alternative to lorlatinib or other therapy.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar